1. Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy
   Mario Scartozzi et al, 2007, Journal of Clinical Oncology CrossRef
2. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition
   Deepika Yadav et al, 2019, Journal of Biomolecular Structure and Dynamics CrossRef
3. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy
   Shadan Ali et al, 2005, Molecular Cancer Therapeutics CrossRef